{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:47:01Z","timestamp":1789498021556,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":4937,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.exphem.2008.08.001","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T05:16:27Z","timestamp":1224134187000},"page":"1673-1681.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Epigenetic silencing of the interferon regulatory factor ICSBP\/IRF8 in human multiple myeloma"],"prefix":"10.1016","volume":"36","author":[{"given":"Marina","family":"Tshuikina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Jernberg-Wiklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"\u00d6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2008.08.001_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.08.001_bib2","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2008.08.001_bib3","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1182\/blood.V89.7.2500","article-title":"Frequent hypermethylation of p16 and p15 genes in multiple myeloma","volume":"89","author":"Ng","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.08.001_bib4","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1182\/blood.V93.12.4347","article-title":"Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies","volume":"93","author":"Katzenellenbogen","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.08.001_bib5","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2002-06-1735","article-title":"SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma","volume":"101","author":"Galm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.08.001_bib6","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/sj.leu.2404939","article-title":"Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma","volume":"21","author":"Chim","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2008.08.001_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1359-6101(97)00019-1","article-title":"The growing family of interferon regulatory factors","volume":"8","author":"Nguyen","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.exphem.2008.08.001_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(99)00262-0","article-title":"Interferon regulatory factors: the next generation","volume":"237","author":"Mamane","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.exphem.2008.08.001_bib9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1101\/gad.1104803","article-title":"IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development","volume":"17","author":"Lu","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.exphem.2008.08.001_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ni1357","article-title":"Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination","volume":"7","author":"Klein","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2008.08.001_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng1097-226","article-title":"Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma","volume":"17","author":"Iida","year":"1997","journal-title":"Nat Genet."},{"key":"10.1016\/j.exphem.2008.08.001_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81348-3","article-title":"Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene","volume":"87","author":"Holtschke","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2008.08.001_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood.V91.1.22","article-title":"Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias","volume":"91","author":"Schmidt","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.08.001_bib14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.onc.1206270","article-title":"Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines","volume":"22","author":"Arguello","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2008.08.001_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20051450","article-title":"Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8\/IFN consensus sequence-binding protein","volume":"203","author":"Lee","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2008.08.001_bib16","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1158\/0008-5472.CAN-06-4068","article-title":"Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.exphem.2008.08.001_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.190.3.411","article-title":"Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein","volume":"190","author":"Gabriele","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2008.08.001_bib18","first-page":"477","article-title":"Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient","volume":"7","author":"Nilsson","year":"1970","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.exphem.2008.08.001_bib19","series-title":"Human Cell Culture vol. 3","first-page":"81","article-title":"Multiple myeloma cell lines","author":"Jernberg-Wiklund","year":"2000"},{"issue":"8278","key":"10.1016\/j.exphem.2008.08.001_bib20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(82)91933-X","article-title":"Human plasmacytoma with an unusual karyotype growing in vitro and producing light-chain immunoglobulin","volume":"1","author":"Karpas","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2008.08.001_bib21","first-page":"775","article-title":"Establishment and characterization of a CD5 positive, immunosuppressive human myeloma cell line","volume":"4","author":"Scibienski","year":"1990","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2008.08.001_bib22","first-page":"940","article-title":"Factors affecting the in vitro evolution of a myeloma cell line","volume":"6","author":"Scibienski","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2008.08.001_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF01000590","article-title":"Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study","volume":"36","author":"Diehl","year":"1978","journal-title":"Blut"},{"key":"10.1016\/j.exphem.2008.08.001_bib24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/1097-0142(19920915)70:6<1528::AID-CNCR2820700614>3.0.CO;2-U","article-title":"The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia","volume":"70","author":"Kubonishi","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2008.08.001_bib25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V73.4.1020.1020","article-title":"The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation","volume":"73","author":"Pegoraro","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.08.001_bib26","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3181\/00379727-125-32327","article-title":"Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma","volume":"125","author":"Matsuoka","year":"1967","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.exphem.2008.08.001_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ijc.2910170504","article-title":"Establishment and characterization of a human histiocytic lymphoma cell line (U-937)","volume":"17","author":"Sundstrom","year":"1976","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2008.08.001_bib28","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1084\/jem.152.6.1709","article-title":"Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line","volume":"152","author":"Gillis","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2008.08.001_bib29","first-page":"276","article-title":"Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma","volume":"22","author":"Menezes","year":"1975","journal-title":"Biomedicine"},{"key":"10.1016\/j.exphem.2008.08.001_bib30","first-page":"485","article-title":"Chromosome evolution of near-haploid clones in an established human acute lymphoblastic leukemia cell line (NALM-16)","volume":"64","author":"Kohno","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.exphem.2008.08.001_bib31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0145-2126(98)00050-2","article-title":"Establishment and characterization of human B cell precursor-leukemia cell lines","volume":"22","author":"Matsuo","year":"1998","journal-title":"Leuk Res."},{"key":"10.1016\/j.exphem.2008.08.001_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4049\/jimmunol.127.2.412","article-title":"T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF","volume":"127","author":"Muraguchi","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2008.08.001_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0065-230X(08)60886-6","article-title":"Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma","volume":"37","author":"Nilsson","year":"1982","journal-title":"Adv Cancer Res."},{"key":"10.1016\/j.exphem.2008.08.001_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3083.2006.01827.x","article-title":"Inhibition of monocytic differentiation by phosphorylation-deficient Stat1 is associated with impaired expression of Stat2, ICSBP\/IRF8 and C\/EBPepsilon","volume":"64","author":"Dimberg","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.exphem.2008.08.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.exphem.2008.08.001_bib36","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.08.001_bib37","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1073\/pnas.87.10.3743","article-title":"An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes","volume":"87","author":"Driggers","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2008.08.001_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"Feinberg","year":"2006","journal-title":"Nat Rev Genet."},{"key":"10.1016\/j.exphem.2008.08.001_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2002-10-3161","article-title":"Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation","volume":"102","author":"Tarte","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.08.001_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1432-1327.2001.01869.x","article-title":"Methyl-CpG-binding proteins. Targeting specific gene repression","volume":"268","author":"Ballestar","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.exphem.2008.08.001_bib41","first-page":"310","article-title":"Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop","volume":"6","author":"Jernberg-Wiklund","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2008.08.001_bib42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ng1950","article-title":"Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer","volume":"39","author":"Schlesinger","year":"2007","journal-title":"Nat Genet."},{"key":"10.1016\/j.exphem.2008.08.001_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ng1972","article-title":"A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing","volume":"39","author":"Ohm","year":"2007","journal-title":"Nat Genet."},{"key":"10.1016\/j.exphem.2008.08.001_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/5047","article-title":"Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer","volume":"21","author":"Cameron","year":"1999","journal-title":"Nat Genet."}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X0800386X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X0800386X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:27:19Z","timestamp":1759566439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X0800386X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0301472X0800386X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2008.08.001","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic silencing of the interferon regulatory factor ICSBP\/IRF8 in human multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2008.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}